A company devoted to advancing orthopedic care through non-surgical adult stem cell procedures, Regenerative Sciences, Inc. recently announced the start of a clinical research study in Chicago on the use of autologous stem cells in treating knee osteoarthritis.
Age is the primary risk factor for knee osteoarthritis, but young people can get the condition from anything from hereditary reasons to injury to infection to being overweight. If you live in Chicago and want to prevent or treat knee osteoarthritis due to weight, liposuction may be the procedure for you. The surgical treatment could help reduce the weight on your joints and, in turn, prevent the onset of knee osteoarthritis.
In collaboration with Regenexx Physician Network Provider, Dr. Mitchell Sheinkop will conduct the study with the Regenexx procedure, a viable alternative to surgery that uses a patient’s own stem cells to help repair a broad range of common injuries and degenerative conditions. Regenexx patients experience little to no recovery time and avoid the lengthy rehabilitation period associated with most surgeries.
One of the most common degenerative join conditions in the United States today, knee osteoarthritis affects millions of individuals and results in approximately 700,000 knee replacements each year. The first of its kind, the clinical research study will measure and compare patient outcomes following the Regenexx-SD or “same day” stem cell therapy against those from a control group or individuals undergoing exercise therapy and other non-surgical modalities, as well as historical results of patients who have undergone knee replacement surgery.
“Regenexx procedures are the most researched stem cell procedures in the United States and have been the subject of many published research papers on the use of stem cells for orthopedic conditions,” Christopher J. Centeno, M.D., chief executive officer of Regenerative Sciences, said in a press release. “This study is a big step in quantifying the effectiveness of the procedure for knee osteoarthritis, with the added benefit of bringing additional awareness of regenerative stem cell treatments to both the medical community and the general public.”
“Regenerative Sciences continues to be at the forefront of regenerative orthopedic medicine in the United States,” Dr. Mitchell Sheinkop, head of the Chicago study, said in a press release. “Having performed thousands of knee replacements during my 38 years as a joint replacement surgeon, I’m excited to be leading this important study. I have seen the ability of these new biologic treatments to help heal injuries and degenerative conditions without surgery and I believe they will soon become the new-normal for treating many orthopedic conditions.”
If you are a Chicago resident and wish to look into liposuction to prevent or treat knee osteoarthritis, please feel free to schedule a consultation or contact one of our representatives today!